The analysis of fraction of hematopoietic precursors expressing checkpoint ligands demonstrated that a significantly higher fraction of CD117+CD34+HLA-DRlow in MDS patients carried PD-1L (31,06±23,28% vs 12,04±7,48%, p = 0.0093). Here, CD34 is linked to myelodysplastic syndrome.